Plus Therapeutics Inc (NASDAQ: PSTV) is -51.47% lower on its value in year-to-date trading and has touched a low of $0.24 and a high of $2.67 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PSTV stock was last observed hovering at around $0.59 in the last trading session, with the day’s loss setting it -0.03%.
Currently trading at $0.56, the stock is -40.58% and -49.43% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.37 million and changing -4.76% at the moment leaves the stock -60.39% off its SMA200. PSTV registered -65.97% loss for a year compared to 6-month loss of -62.29%. The firm has a 50-day simple moving average (SMA 50) of $1.104 and a 200-day simple moving average (SMA200) of $1.40905.
The stock witnessed a -54.99% gain in the last 1 month and extending the period to 3 months gives it a -58.04%, and is -60.97% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 27.55% over the week and 41.64% over the month.
Plus Therapeutics Inc (PSTV) has around 20 employees, a market worth around $3.29M and $5.72M in sales. Profit margin for the company is -225.07%. Distance from 52-week low is 132.54% and -79.10% from its 52-week high.
with sales reaching $1.19M over the same period.The EPS is expected to grow by 57.50% this year, but quarterly earnings will post 12.52% year-over-year. Quarterly sales are estimated to shrink -9.18% in year-over-year returns.
Plus Therapeutics Inc (PSTV) Top Institutional Holders
11.0 institutions hold shares in Plus Therapeutics Inc (PSTV), with institutional investors hold 11.78% of the company’s shares. The shares outstanding are 5.90M, and float is at 5.75M with Short Float at 2.44%. Institutions hold 11.50% of the Float.
Plus Therapeutics Inc (PSTV) Insider Activity
The most recent transaction is an insider purchase by Hawkins Richard J, the company’s Director. SEC filings show that Hawkins Richard J bought 4,000 shares of the company’s common stock on Sep 13 ’24 at a price of $1.50 per share for a total of $5996.0. Following the purchase, the insider now owns 15188.0 shares.
Plus Therapeutics Inc disclosed in a document filed with the SEC on Sep 12 ’24 that Hawkins Richard J (Director) bought a total of 6,285 shares of the company’s common stock. The trade occurred on Sep 12 ’24 and was made at $1.35 per share for $8512.0. Following the transaction, the insider now directly holds 11188.0 shares of the PSTV stock.
Still, SEC filings show that on Sep 11 ’24, Petersen Greg (Director) acquired 12,500 shares at an average price of $1.35 for $16875.0. The insider now directly holds 48,921 shares of Plus Therapeutics Inc (PSTV).
